These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7764073)

  • 1. Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, lamivudine): a potent anti-HIV agent.
    Mahmoudian M; Baines BS; Drake CS; Hale RS; Jones P; Piercey JE; Montgomery DS; Purvis IJ; Storer R; Dawson MJ
    Enzyme Microb Technol; 1993 Sep; 15(9):749-55. PubMed ID: 7764073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective enzymatic biotransformation of 2'-deoxy-3'-thiacytidine (BCH 189) monitored by capillary electrophoresis.
    Rogan MM; Drake C; Goodall DM; Altria KD
    Anal Biochem; 1993 Feb; 208(2):343-7. PubMed ID: 8383931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
    Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
    Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intracellular phosphorylation of (-)-2'-deoxy-3'-thiacytidine (3TC) and the incorporation of 3TC 5'-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma.
    Gray NM; Marr CL; Penn CR; Cameron JM; Bethell RC
    Biochem Pharmacol; 1995 Sep; 50(7):1043-51. PubMed ID: 7575660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
    Shewach DS; Liotta DC; Schinazi RF
    Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular metabolism of (-) enantiomeric 2'-deoxy-3'-thiacytidine.
    Cammack N; Rouse P; Marr CL; Reid PJ; Boehme RE; Coates JA; Penn CR; Cameron JM
    Biochem Pharmacol; 1992 May; 43(10):2059-64. PubMed ID: 1318048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.
    Coates JA; Cammack N; Jenkinson HJ; Mutton IM; Pearson BA; Storer R; Cameron JM; Penn CR
    Antimicrob Agents Chemother; 1992 Jan; 36(1):202-5. PubMed ID: 1590690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal disposition and drug interaction screening of (-)-2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney.
    Sweeney KR; Hsyu PH; Statkevich P; Taft DR
    Pharm Res; 1995 Dec; 12(12):1958-63. PubMed ID: 8786973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of 2'-deoxy-3'-thiacytidine (3TC) in human urine by liquid chromatography: direct injection with column switching.
    Morris DM; Selinger K
    J Pharm Biomed Anal; 1994 Feb; 12(2):255-64. PubMed ID: 8003552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.
    Chang CN; Doong SL; Zhou JH; Beach JW; Jeong LS; Chu CK; Tsai CH; Cheng YC; Liotta D; Schinazi R
    J Biol Chem; 1992 Jul; 267(20):13938-42. PubMed ID: 1321132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine.
    Kavlick MF; Shirasaka T; Kojima E; Pluda JM; Hui F; Yarchoan R; Mitsuya H
    Antiviral Res; 1995 Oct; 28(2):133-46. PubMed ID: 8585767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine.
    Skalski V; Chang CN; Dutschman G; Cheng YC
    J Biol Chem; 1993 Nov; 268(31):23234-8. PubMed ID: 7693686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
    Harker AJ; Evans GL; Hawley AE; Morris DM
    J Chromatogr B Biomed Appl; 1994 Jul; 657(1):227-32. PubMed ID: 7952073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.
    Wainberg MA; Salomon H; Gu Z; Montaner JS; Cooley TP; McCaffrey R; Ruedy J; Hirst HM; Cammack N; Cameron J
    AIDS; 1995 Apr; 9(4):351-7. PubMed ID: 7540846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
    Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
    Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection.
    Pluda JM; Cooley TP; Montaner JS; Shay LE; Reinhalter NE; Warthan SN; Ruedy J; Hirst HM; Vicary CA; Quinn JB
    J Infect Dis; 1995 Jun; 171(6):1438-47. PubMed ID: 7769277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent.
    Lisignoli G; Monaco MC; Degrassi A; Toneguzzi S; Ricchi E; Costigliola P; Facchini A
    Clin Exp Immunol; 1993 Jun; 92(3):455-9. PubMed ID: 8390335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.
    Balzarini J; Wedgwood O; Kruining J; Pelemans H; Heijtink R; De Clercq E; McGuigan C
    Biochem Biophys Res Commun; 1996 Aug; 225(2):363-9. PubMed ID: 8753770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M; Kemp SD; Parry NR; Larder BA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.